S-Form Pharma SPRL
S-Form Pharma reported total assets of 20,430 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Aug 2026).
The score of S-Form Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -42 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
S-Form Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 28 Oct 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 20 May 2022
S-Form Pharma's financial analysis
- Solvency-563.6%sector median: 61.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of S-Form Pharma
S-Form Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0715.471.307
- VAT number
- BE0715471307
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 04 Dec 2018
- Registered office
- 1040 Etterbeek
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
S-Form Pharma (SPRL) has been based in Etterbeek since 2018, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 4,810 € and equity of −115,150 €; its revenue is not published. Its solvency stands at -563.6%, below the median of its sector (61.2%).
Companies similar to S-Form Pharma
Companies in the same business, of comparable size and area, outside its group.
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Pranarom MED Manufacture of basic pharmaceutical products Ath · balance sheet 24,820 €
- Chris Pharma Works Manufacture of basic pharmaceutical products Profondeville · balance sheet 24,086 €
- CFG Pharma Manufacture of basic pharmaceutical products Courcelles · balance sheet 50,919 €
- Premium Pharma Retail Manufacture of basic pharmaceutical products Molenbeek-Saint-Jean · balance sheet 34,216 €
- Evarmed Manufacture of basic pharmaceutical products Diepenbeek · balance sheet 51,346 €
- Xpert Protein Manufacture of pharmaceutical preparations Ghent · balance sheet 10,960 €
- SpectronRx Europe Manufacture of basic pharmaceutical products Grimbergen · balance sheet 198,933 €
Frequently asked questions about S-Form Pharma
What is the revenue of S-Form Pharma?
S-Form Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of S-Form Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0715471307 for S-Form Pharma, if the company is VAT-registered. Its company number (CBE) is 0715.471.307.
Where is the registered office of S-Form Pharma?
According to the CBE register, the registered office of S-Form Pharma is in 1040 Etterbeek.
What is the equity of S-Form Pharma?
At the close of the 2025 financial year, the equity of S-Form Pharma amounts to -115,150 €, a solvency of -563.6% of total assets.
Who manages S-Form Pharma?
The register lists 2 active mandates at S-Form Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of S-Form Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →